Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Farabi Pharmaceutical's selling, general, & admin. expense for the
three
months ended in . 20 was IRR0.00 Mil.
Farabi Pharmaceutical does not have enough years/quarters to calculate its selling, general, & admin. expense for the trailing twelve months (TTM) ended in . 20.
Farabi Pharmaceutical (XTEH:DFRB1) Selling, General, & Admin. Expense Explanation
An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.
Warren Buffett likes companies with consistent SGA as the percentage of gross profit.
Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.
If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.
Farabi Pharmaceutical Selling, General, & Admin. Expense Related Terms
Farabi Pharmaceutical Selling, General, & Admin. Expense Historical Data
* Premium members only.
The historical data trend for Farabi Pharmaceutical's Selling, General, & Admin. Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Farabi Pharmaceutical Selling, General, & Admin. Expense Chart
Farabi Pharmaceutical Annual Data
Trend
Selling, General, & Admin. Expense
Farabi Pharmaceutical Quarterly Data
Selling, General, & Admin. Expense
XTEH:DFRB1 vs IMNPQ, INNV: Selling, General, & Admin. Expense Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Farabi Pharmaceutical's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Farabi Pharmaceutical Selling, General, & Admin. Expense vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Farabi Pharmaceutical's Selling, General, & Admin. Expense distribution charts can be found below:
* The bar in red indicates where Farabi Pharmaceutical's Selling, General, & Admin. Expense falls into.
Farabi Pharmaceutical Selling, General, & Admin. Expense Calculation
Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.
What does a Selling, General, & Admin. Expense of IRR Mil mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a Selling, General, & Admin. Expense of IRR Mil as of . 20. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's Selling, General, & Admin. Expense too high?
Farabi Pharmaceutical's current Selling, General, & Admin. Expense is IRR Mil.
How does Farabi Pharmaceutical's Selling, General, & Admin. Expense compare to IMNPQ and INNV?
Farabi Pharmaceutical's Selling, General, & Admin. Expense of IRR Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Drug Manufacturers company?
A good Selling, General, & Admin. Expense depends on the Drug Manufacturers industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Farabi Pharmaceutical and its competitors. Farabi Pharmaceutical's current Selling, General, & Admin. Expense is IRR Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current Selling, General, & Admin. Expense of IRR Mil. The current Selling, General, & Admin. Expense is IRR Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current Selling, General, & Admin. Expense is IRR Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTEH:DFRB1 has been successfully added to your 
